Medical device industry leaders to focus on blockchain technology,
M&A trends and federal policy

DENVER–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/cobioscience?src=hash” target=”_blank”gt;#cobiosciencelt;/agt;–Colorado
BioScience Association (CBSA) focuses on the opportunities offered
by blockchain technology for medical device companies with insights from
Colorado thought leaders focused on blockchain adoption in healthcare,
including BurstIQ and CORHIO, at its annual Medical Device Symposium.
The event will be held at the Westin Westminster on March 7.

Jennifer Jones Paton, President & CEO of CBSA, says:
“Colorado
is an emerging blockchain technology hub and medical devices rank among
our state’s top exports. We’re pleased to bring innovators in these
technologies together to explore the potential of blockchain to advance
healthcare and support improved health and quality of life for patients.”

Additionally, speakers and panelists will provide their perspectives on
developing and launching new products, discuss the M&A outlook and
review federal policies impacting medical device manufacturers in
sessions including:

• Federal policy preview by Brendan Benner, Vice President of Public
  Affairs for the Medical Device Manufacturers Association.
• New national data and insights on the medtech sector from Derek
  Riesenberg, Managing Director, EY-Parthenon Life Sciences Practice.
• Panel discussion: Leaders in MedTech, led by Dan Wittenberg, Partner
  at Snell & Wilmer.
• Panel discussion: Blockchain’s Disruptive Technology, led by Eric
  Kintner, Partner at Snell & Wilmer.

Sponsors of the symposium include: Snell
& Wilmer, Fitzsimons
Innovation Community, and EY.

The conference will be held on March 7, 2019 from 1:30 p.m.-5:00 p.m. at
the Westin Westminster – Lakehouse, 10600 Westminster Blvd. Registration
is $50 for CBSA members and $100 for non-members.

Connect with CBSA: Twitter @COBioscience, Facebook
and LinkedIn

About the Colorado BioScience Association

Colorado BioScience Association champions life science. We serve as the
hub of Colorado’s thriving bioscience sector by connecting innovators to
funding, infrastructure, research and talent. From promising young
companies to established corporations and institutions, we provide
opportunities for networking, education and professional development. We
grow the bioscience workforce and lead business expansion policies to
advance the industry in our state. CBSA represents more than 350 member
organizations, including biotechnology, pharmaceutical, medical device,
diagnostic, ag bio and mobile digital health companies, research and
academic institutions and service providers. Learn more about us at http://www.cobioscience.com.

Contacts

Sheliah Reynolds
Primavera Group for Colorado BioScience Association
(720)
289-4739
[email protected]